Navigation Links
Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
Date:11/10/2009

SAN DIEGO, Nov. 10 /PRNewswire-FirstCall/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported its financial results for its third quarter ended September 30, 2009, and on recent developments and future outlook. Cardium made significant progress since its second quarter 2009 financial report and highlights included:

  • Sale of Cardium's InnerCool Therapies business to Royal Philips Electronics;
  • Completion and announcement of data from the Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of non-healing diabetic ulcers and the Company's plans to meet with the FDA to review the data and proposed outline for a Phase 3 clinical study;
  • Plans for the commercial development of a new product candidate Excellagen(TM), a collagen-based topical gel, through a FDA 510(k) clearance pathway for potential use by physicians in patients with topical wounds, which include diabetic ulcers as well as pressure ulcers, venous ulcers, surgical and trauma wounds, second degree burns, and other types of wounds;
  • Publication of positive findings from the open label multi-center Phase 1/2 Excellarate clinical study in the October 2009 issue of Wound Repair and Regeneration, a peer-reviewed journal of the Wound Healing Society;
  • Plans to develop a DNA-based orthobiologics product portfolio based on a reformulation of the Company's Excellarate product candidate that will initially focus on non-union bone fractures and spinal fusions;
  • Publication of preclinical research published in the scientific journal, Gene Therapy, demonstrating the potential benefits of the Cardium's Gene Activated Matrix technology for accelerating and enhancing periodontal tissue repair and oral implant osseointegration;
  • Completion of two registered direct investments of Cardium's common stock by institutional invest
    '/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Cardium Announces $5.3 Million Registered Direct Offering
2. Cardium Completes $5.3 Million Registered Direct Offering
3. Cardiums Corgentin Preclinical Program Shows High Levels of Targeting to Acutely Ischemic Heart Muscle Following Intracoronary Infusion
4. Cardiums InnerCool Therapies Unit Announces European Commercialization Agreement for Portfolio of Temperature Modulation Systems
5. Cardium Reports on Science Channel Series Featuring InnerCools Endovascular Cooling During Brain Surgery at Stanford University
6. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
7. Cardium Reports on First Quarter 2008 Highlights and Financial Results
8. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
9. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
10. Cardium Launches New AWARE Clinical Study Website
11. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... August 26, 2014 New research ... wearable technology, and inspiration for the International Year ... year’s brighter, busier SPIE Optics + Photonics ... More than 4,400 international scientists, engineers, researchers, developers, ... exhibition, and industry sessions sponsored by SPIE, ...
(Date:8/26/2014)... team of engineers from Singapore has successfully piloted ... for satellite communications. , With the weight of ... constructing a lightweight, low power-consuming, wireless communication system ... has always been a challenge for system designers. ... Centre of Nanyang Technological University in Singapore launched ...
(Date:8/26/2014)... Aug. 26, 2014 An analysis by Replikins, ... all Dengue virus strains in Pubmed, has revealed extensive ... 1944. This conservation and sharing of specific Replikin gene ... Blocker-Vaccine™ candidate, as it did for the H5N1 influenza ... which have been found to be effective (1,2). ...
(Date:8/26/2014)... , Aug. 26, 2014 Technology Applications ... symbol (NUUU) has two (2) wholly- owned subsidiaries, ... subsidiaries harness scientifically advanced technology to provide advanced ... NUUU,s Renuell Int,l, Inc. is launching its ... care products that is made possible because of ...
Breaking Biology Technology:Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 2Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 3Brighter, Busier SPIE Optics + Photonics Draws International Crowd to San Diego 4ZigBee in the Sky 2Technology Applications International Corporation, Trading Symbol NUUU now trading on NASDAQ's Over the Counter Bulletin Board (OTC BB) 2
... WAUSAU, Wis. Fiserv Health announced Wednesday it ... Administrators to gain access to Aetna's PPO network ... Benefits , a Fiserv Health company. This initiative is ... employees who traditionally use third-party administrators. , ,Aetna will ...
... Esser. Those who venture into the conference room at ... and white poster depicting Kelly Hansen as an entrepreneurial superhero. ... color version of the poster is located at Milwaukee's ... the Marvel Comics-inspired Hall of Entrepreneurs because of the tremendous ...
... grown from human embryonic stem cells in a UW-Madison ... proposition on California's ballot this November may affect Wisconsin's ... experts say. If passed, the Stem Cell Research ... $3 billion in tax-free state bonds over 10 years ...
Cached Biology Technology:Fiserv Health and Aetna help employers control health care costs 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 2Entrepreneurial Profile Kelly Hansen, CEO of Neohapsis, Inc. 3Referendum may pull California to the forefront of stem cell research 2Referendum may pull California to the forefront of stem cell research 3Referendum may pull California to the forefront of stem cell research 4Referendum may pull California to the forefront of stem cell research 5
(Date:8/27/2014)... puts into doubt the long-standing belief that a deficiency ... plays a central role in depression. In the ... mice lacking the ability to make serotonin in their ... wisdom) did not show depression-like symptoms. , Donald ... Medical Center and Wayne State University School of Medicine ...
(Date:8/27/2014)... health advocates, campaigns against trans-fats have largely succeeded ... taking aim at sugar for its potential contributions ... are still wrangling over the best way to ... an article in Chemical & Engineering News ... American Chemical Society. , In the article, Stephen ...
(Date:8/27/2014)... shown that piglets can be weaned later with no ... of the study at the University,s Roseworthy campus, published ... an important finding for pig producers. It allows improvements ... , "Sows don,t usually start their oestrous cycles again ... have been weaned," says Ms Alice Weaver, PhD candidate ...
Breaking Biology News(10 mins):New study throws into question long-held belief about depression 2Piglet weaning age no bar to litter frequency 2
... for Experimental Cancer Research (ISREC) have shown that a ... two seemingly contradictory activities -- maintaining stem cells after ... later providing cues to direct their differentiation in a ... development of an embryo from a few seemingly identical ...
... for the growth of brain cells during development appears ... memories, according to researchers at UC Irvine. The findings ... for, cognitive decline associated with normal aging and diseases ... the early online edition of the Proceedings of the ...
... testing fossil teeth, and showed that early human relatives varied ... leaves and fruit when available in addition to seeds, roots, ... we found that they ate lots of different things, and ... Utah geology doctoral student Ben Passey, a coauthor of the ...
Cached Biology News:Who gives stem cells their marching orders? 2Proteins necessary for brain development found to be critical for long-term memory 2A buffet for early human relatives 2A buffet for early human relatives 3A buffet for early human relatives 4
...
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
Full-length cDNA 5-PRIME end of clone CS0DE013YM09 of Placenta of Homo sapiens (human). [Source:Uniprot/SPTREMBL;Acc:Q86TS7] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: